Literature DB >> 28533166

Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Pedro Ayau1, Ana C Bardossy2, Guillermo Sanchez1, Ricardo Ortiz1, Daniela Moreno2, Pamela Hartman2, Khulood Rizvi2, Tyler C Prentiss2, Mary B Perri2, Meredith Mahan2, Vanthida Huang3, Katherine Reyes2, Marcus J Zervos4.   

Abstract

OBJECTIVES: Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections (BSI) are a major health care problem accounting for a large percentage of nosocomial infections. The aim of this study was to identify risk factors associated with 30-day mortality in patients with MRSA BSI.
METHODS: This was a retrospective study performed in Southeast Michigan. Over a 9- year period, a total of 1,168 patients were identified with MRSA BSI. Patient demographics and clinical data were retrieved and evaluated using electronic medical health records.
RESULTS: 30-day mortality during the 9-year study period was 16%. Significant risk factors for 30-day mortality were age, cancer, heart disease, neurologic disease, nursing home residence and Charlson score >3 with Odds Ratio (OR) of 1.03 (CI 1.02-1.04), 2.29 (CI 1.40-3.75), 1.78 (CI 1.20-2.63), 1.65 (CI 1.08-2.25), 1.66 (CI 1.02 - 2.70) and 1.86 (CI 1.18 - 2.95) correspondingly. Diabetes mellitus, peripheral vascular disease (PVD), and readmission were protective factors for 30-day mortality with OR of 0.53 (CI 0.36-0.78), 0.46 (CI 0.26-0.84) and 0.13 (CI0.05 - 0.32) respectively.
CONCLUSIONS: Our study identified significant risk factors for 30-day mortality in patients with MRSA BSI. Interestingly, diabetes mellitus, PVD and readmission were protective effects on 30-day mortality. There was no statistically significant variability in 30-day mortality over the 9-year study period.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  30-day mortality; Methicillin-resistant Staphylococcus aureus; blood stream infection; risk factors

Mesh:

Year:  2017        PMID: 28533166     DOI: 10.1016/j.ijid.2017.05.010

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  8 in total

1.  Bloodstream infection caused by S. aureus in patients with cancer: a 10-year longitudinal single-center study.

Authors:  Omar Yaxmehen Bello-Chavolla; Jessica Paola Bahena-Lopez; Pamela Garciadiego-Fosass; Patricia Volkow; Alejandro Garcia-Horton; Consuelo Velazquez-Acosta; Diana Vilar-Compte
Journal:  Support Care Cancer       Date:  2018-06-08       Impact factor: 3.603

2.  Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments.

Authors:  Erin K McCreary; Ravina Kullar; Matthew Geriak; Evan J Zasowski; Khulood Rizvi; Lucas T Schulz; Krista Ouellette; Logan Vasina; Fadi Haddad; Michael J Rybak; Marcus J Zervos; George Sakoulas; Warren E Rose
Journal:  Open Forum Infect Dis       Date:  2019-12-31       Impact factor: 3.835

3.  Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.

Authors:  Zhouqi Li; Hemu Zhuang; Guannan Wang; Hui Wang; Ying Dong
Journal:  BMC Infect Dis       Date:  2021-01-14       Impact factor: 3.090

Review 4.  Epidemiology and Pathogenesis of Staphylococcus Bloodstream Infections in Humans: a Review.

Authors:  Klaudia Lisowska-Łysiak; Ryszard Lauterbach; Jacek Międzobrodzki; Maja Kosecka-Strojek
Journal:  Pol J Microbiol       Date:  2021-02-24

5.  Preexisting Atrial Fibrillation Associated with Higher Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Analysis of the National Inpatient Sample.

Authors:  Timothy McCann; Michael Fatuyi; Neha Patel; Deepali B Sharath; Anar S Patel
Journal:  Interdiscip Perspect Infect Dis       Date:  2022-07-19

6.  View point: gaps in the current guidelines for the prevention of Methicillin-resistant Staphylococcus aureus surgical site infections.

Authors:  Kevin T Kavanagh; Said Abusalem; Lindsay E Calderon
Journal:  Antimicrob Resist Infect Control       Date:  2018-09-18       Impact factor: 4.887

7.  Staphylococcus aureus bacteremia in a secondary level Spanish hospital: clinical implications of high vancomycin MIC.

Authors:  G Abelenda Alonso; M D Corbacho Loarte; R Núñez Ramos; M Cervero Jiménez; J J Jusdado Ruiz-Capillas
Journal:  Rev Esp Quimioter       Date:  2018-05-04       Impact factor: 1.553

8.  Methicillin-resistant Staphylococcus aureus of the clonal lineage ST5-SCCmecII-t2460 was associated with high mortality in a Wuhan hospital.

Authors:  Xuehan Li; Jing Zhang; Yifan Zhang; Junying Zhou; Xinwei Li; Ruo Feng; Yirong Li
Journal:  Braz J Microbiol       Date:  2021-07-08       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.